Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2021-04-26 Management Reports
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
2020年度监事会工作报告
Management Reports Classification · 95% confidence The document is titled '2020 年度监事会工作报告' which translates to '2020 Supervisory Board Work Report'. It details the supervisory board's activities, oversight of company operations, financial audits, internal controls, and compliance with laws and regulations for the year 2020. It includes specific financial figures and audit opinions but is not a full annual report or audit report itself. The document is a report from the supervisory board summarizing their work and oversight for the year, which aligns with a Management Report type filing rather than a full Annual Report or Audit Report. The length is 2123 characters, indicating a concise report rather than a full financial statement. Therefore, the best fit is Management Reports (MDA).
2021-04-26 Chinese
2021年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2021 First Quarter Report" of 大博医疗科技股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as income, profit, cash flow, asset and liability changes, shareholder information, and investment project progress for the first quarter of 2021. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year confirms it is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2021
2021-04-26 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Dabao Medical Technology Co., Ltd. It details the approval of various reports and proposals related to the 2020 fiscal year, including the 2020 Supervisory Board Work Report, 2020 Financial Final Accounts Report, 2020 Profit Distribution Proposal, 2020 Annual Report and Summary, 2020 Internal Control Self-Evaluation Report, and the 2021 First Quarter Report. The document also mentions that these reports and proposals will be submitted to the 2020 Annual General Meeting for approval. The document is not the reports themselves but a formal announcement of the Supervisory Board's resolutions and approvals regarding these reports and proposals. The document length is 3983 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the MENU VS MEAL RULE, this document should be classified as a Regulatory Filing (RNS) because it is a general regulatory announcement of meeting resolutions and approvals, not the full annual or quarterly reports themselves.
2021-04-26 Chinese
2020年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2020 年年度报告摘要" which translates to "2020 Annual Report Summary". It contains detailed financial data for the year 2020, including revenue, net profit, earnings per share, and other financial indicators. It also discusses business operations, product lines, market conditions, and company strategy. The length of the document (over 14,000 characters) and the presence of comprehensive financial and operational information indicate this is a substantive report rather than a brief announcement or summary. The document is clearly an annual report or a summary thereof, which aligns with the definition of an Annual Report (10-K). Therefore, the appropriate classification is Annual Report (10-K). FY 2020
2021-04-26 Chinese
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2020 年度内部控制自我评价报告' which translates to '2020 Annual Internal Control Self-Evaluation Report'. It is issued by the company's board of directors and discusses the evaluation of the internal control system effectiveness as of December 31, 2020. The content includes detailed descriptions of internal control environment, risk assessment, control activities, information systems, and internal supervision. It also includes conclusions on the absence of significant internal control deficiencies. The document is a comprehensive report on internal control self-evaluation, which is a type of audit-related report focusing on internal controls rather than a full annual report or financial statements. It is not a brief announcement or a certification letter but a substantive report. Therefore, it fits best under the category of Audit Report / Information (AR). FY 2020
2021-04-26 Chinese
大博医疗外汇衍生品交易业务管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled '外汇衍生品交易业务管理制度' (Foreign Exchange Derivatives Trading Business Management System) issued by 大博医疗科技股份有限公司. It outlines the company's rules, principles, approval processes, risk control, confidentiality, and information disclosure related to foreign exchange derivatives trading. There is no indication that this is a financial report, earnings release, or regulatory filing. It is not an announcement or a brief summary but a comprehensive internal governance document related to the management of a specific business activity. This fits best under Governance Information (CGR), which covers reports detailing the company's internal rules and governance practices. The document length is 3096 characters, which is relatively short but contains substantive governance content rather than a mere announcement or certification. Therefore, the classification is CGR with high confidence.
2021-04-26 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.